All of us at Endurance for Everyone, LLC encourage charity racing of all types. It makes a big difference in your own healthy lifestyle while at the same time offering support and aid to those in the world that need it.
We do many races as part of Team in Training. Currently, the Team in Training events we are signed up for and raising money toward are:
St. Anthony’s Triathlon on April 29, 2018
By selecting the linkyou can make a donation to Team in Training to support research toward the treatment and eradication of blood cancers.
Created 23 years ago, The Leukemia & Lymphoma Society’s (LLS) Team In Training (TNT), has grown to be the world’s largest and most successful endurance sports charity training program. Since its inception in 1988, when a team of 38 runners trained together for the New York City Marathon and raised $320,000, TNT has prepared more than 500,000 people to achieve their dream of completing a marathon, half marathon, triathlon, 100-mile (century) bicycle ride or hike adventure. Those participants have raised a remarkable $1 billion to support blood cancer research and patient services.
Whether you are a novice or a seasoned athlete, TNT’s team-focused philosophy will help get you across the finish line in the event of your choice. Participants cite many reasons for joining the program, including the opportunity to make friends and have fun as part of a supportive team; the satisfaction of supporting cancer research and helping patients live better longer lives; the high-caliber coaching that helps you accomplish your goal; and getting fit. Many participants train in honor of a loved one who has been touched by cancer (or are cancer survivors themselves). Local blood cancer patients, known as honored teammates, cheer participants along from training to event weekend. Those who have completed TNT say it is a life-changing experience.
The money raised by TNT participants has enabled LLS to fund millions of dollars of research to help advance new treatments and cures for leukemia, lymphoma, and myeloma, and provide critical education and support to cancer patients and their families.
Nearly 50% of all cancer drugs approved by the FDA during the past decade were for blood cancers. And they are helping other patients as well. Five of those drugs have been approved for patients with solid tumors and others are being tested for other indications.
Survival rates for children with leukemia have improved from 3% 40 years ago to 90% today; Hodgkin lymphoma patient survival rates have more than doubled to 88% since the 1960s. And the survival rate for myeloma patients tripled in past decade.